106 related articles for article (PubMed ID: 27222007)
1. Preparation and application of a novel monoclonal antibody specific for human B7-H3.
Shi J; Zhang DL; Cui ZC; Wang HM
Mol Med Rep; 2016 Jul; 14(1):943-8. PubMed ID: 27222007
[TBL] [Abstract][Full Text] [Related]
2. [Identification and characterization of monoclonal antibody Y4F11 against human B7-H3].
Shi Z; Hu Y; Chen H; Fu F; Zhang X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Oct; 32(10):1402-1406. PubMed ID: 27667469
[TBL] [Abstract][Full Text] [Related]
3. Fully human anti-B7-H3 recombinant antibodies inhibited tumor growth by increasing T cell infiltration.
Li L; Nian S; Liu Q; Zhang B; Jimu W; Li C; Huang Z; Hu Q; Huang Y; Yuan Q
Int Immunopharmacol; 2024 May; 132():111926. PubMed ID: 38552297
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effects of anti-B7-H3 antibody in an ovalbumin-induced mouse asthma model.
Chen ZR; Zhang GB; Wang YQ; Yan YD; Zhou WF; Zhu C; Chen Y; Wang J; Ji W
Ann Allergy Asthma Immunol; 2013 Oct; 111(4):276-81. PubMed ID: 24054363
[TBL] [Abstract][Full Text] [Related]
5. Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy.
Picarda E; Ohaegbulam KC; Zang X
Clin Cancer Res; 2016 Jul; 22(14):3425-3431. PubMed ID: 27208063
[TBL] [Abstract][Full Text] [Related]
6. A novel monoclonal antibody against mouse B7-H3 developed in rats.
Yan R; Yang S; Sun J; Chen X; Zhang G; Feng P; Zhang X
Hybridoma (Larchmt); 2012 Aug; 31(4):267-71. PubMed ID: 22894780
[TBL] [Abstract][Full Text] [Related]
7. Development of DS-5573a: A novel afucosylated mAb directed at B7-H3 with potent antitumor activity.
Nagase-Zembutsu A; Hirotani K; Yamato M; Yamaguchi J; Takata T; Yoshida M; Fukuchi K; Yazawa M; Takahashi S; Agatsuma T
Cancer Sci; 2016 May; 107(5):674-81. PubMed ID: 26914241
[TBL] [Abstract][Full Text] [Related]
8. Development of an Fc-enhanced anti-B7-H3 monoclonal antibody with potent antitumor activity.
Loo D; Alderson RF; Chen FZ; Huang L; Zhang W; Gorlatov S; Burke S; Ciccarone V; Li H; Yang Y; Son T; Chen Y; Easton AN; Li JC; Rillema JR; Licea M; Fieger C; Liang TW; Mather JP; Koenig S; Stewart SJ; Johnson S; Bonvini E; Moore PA
Clin Cancer Res; 2012 Jul; 18(14):3834-45. PubMed ID: 22615450
[TBL] [Abstract][Full Text] [Related]
9. [Preparation and characterization of anti-human B7-H4 monoclonal antibodies].
Xu H; Fang P; Liu YP; Shao Y; Gu ZJ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Aug; 27(8):887-90. PubMed ID: 21806888
[TBL] [Abstract][Full Text] [Related]
10. Potential role of soluble B7-H3 in liver immunopathogenesis during chronic HBV infection.
Luan Y; Ju J; Luo L; Zhang Z; Wang J; Zhu DM; Cheng L; Zhang SY; Chen L; Wang FS; Wang S
J Viral Hepat; 2012 Jan; 19(1):23-31. PubMed ID: 22187944
[TBL] [Abstract][Full Text] [Related]
11. BTNL8, a butyrophilin-like molecule that costimulates the primary immune response.
Chapoval AI; Smithson G; Brunick L; Mesri M; Boldog FL; Andrew D; Khramtsov NV; Feshchenko EA; Starling GC; Mezes PS
Mol Immunol; 2013 Dec; 56(4):819-28. PubMed ID: 24036152
[TBL] [Abstract][Full Text] [Related]
12. Anti-B7-H3 monoclonal antibody ameliorates the damage of acute experimental pancreatitis by attenuating the inflammatory response.
Zhuang X; Shen J; Jia Z; Wu A; Xu T; Shi Y; Xu C
Int Immunopharmacol; 2016 Jun; 35():1-6. PubMed ID: 27003113
[TBL] [Abstract][Full Text] [Related]
13. B7-H3 as a promising target for cytotoxicity T cell in human cancer therapy.
Ma J; Ma P; Zhao C; Xue X; Han H; Liu C; Tao H; Xiu W; Cai J; Zhang M
Oncotarget; 2016 May; 7(20):29480-91. PubMed ID: 27121051
[TBL] [Abstract][Full Text] [Related]
14. B7-H3-mediated tumor immunology: Friend or foe?
Wang L; Kang FB; Shan BE
Int J Cancer; 2014 Jun; 134(12):2764-71. PubMed ID: 24013874
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of B7-H3 reduces the glycolytic capacity and sensitizes breast cancer cells to AKT/mTOR inhibitors.
Nunes-Xavier CE; Karlsen KF; Tekle C; Pedersen C; Øyjord T; Hongisto V; Nesland JM; Tan M; Sahlberg KK; Fodstad Ø
Oncotarget; 2016 Feb; 7(6):6891-901. PubMed ID: 26771843
[TBL] [Abstract][Full Text] [Related]
16. [Eukaryotic expression of recombinant B7-H3Ig protein and its effects on T cells].
Chen L; Zhang G; Zhu Y; Zhang X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jan; 29(1):27-30. PubMed ID: 23294715
[TBL] [Abstract][Full Text] [Related]
17. [B7-H3 monoclonal antibody attenuates the inflammation and tissue injury in mice with cerulein-induced acute pancreatitis].
Zhuang X; Xu C
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Mar; 32(3):323-7. PubMed ID: 26927550
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of B7-H3 (CD276) directs the differentiation of human marrow stromal cells to osteoblasts.
Xu L; Zhang G; Zhou Y; Chen Y; Xu W; Wu S; Zhang X
Immunobiology; 2011 Dec; 216(12):1311-7. PubMed ID: 21893365
[TBL] [Abstract][Full Text] [Related]
19. Characterization and application of two novel monoclonal antibodies against 2IgB7-H3: expression analysis of 2IgB7-H3 on dendritic cells and tumor cells.
Zhang GB; Zhou H; Chen YJ; Ge Y; Xie F; Shi Q; Ma HB; Fei M; Zhang XG
Tissue Antigens; 2005 Aug; 66(2):83-92. PubMed ID: 16029427
[TBL] [Abstract][Full Text] [Related]
20. 4IgB7-H3 is the major isoform expressed on immunocytes as well as malignant cells.
Zhou YH; Chen YJ; Ma ZY; Xu L; Wang Q; Zhang GB; Xie F; Ge Y; Wang XF; Zhang XG
Tissue Antigens; 2007 Aug; 70(2):96-104. PubMed ID: 17610414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
